Business Description
Medipal Holdings Corp
NAICS : 424210
ISIN : JP3268950007
Compare
Compare
Traded in other countries / regions
7459.JapanMAHLY.USA59Z.Germany IPO Date
1995-09-14Description
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.33 | |||||
| Interest Coverage | 1450.33 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.83 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | -0.2 | |||||
| 3-Year EPS without NRI Growth Rate | 2.7 | |||||
| 3-Year FCF Growth Rate | -54.4 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.75 | |||||
| 9-Day RSI | 36.46 | |||||
| 14-Day RSI | 45 | |||||
| 6-1 Month Momentum % | 36.87 | |||||
| 12-1 Month Momentum % | 35.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 19.72 | |||||
| Days Sales Outstanding | 80.68 | |||||
| Days Payable | 106.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.11 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| 3-Year Dividend Growth Rate | 3.9 | |||||
| Forward Dividend Yield % | 2.39 | |||||
| 5-Year Yield-on-Cost % | 2.37 | |||||
| Shareholder Yield % | 1.99 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.68 | |||||
| Operating Margin % | 1.4 | |||||
| Net Margin % | 1.22 | |||||
| ROE % | 7.49 | |||||
| ROA % | 2.39 | |||||
| ROIC % | 5.63 | |||||
| ROC (Joel Greenblatt) % | 26.85 | |||||
| ROCE % | 9.93 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.9 | |||||
| PE Ratio without NRI | 12.9 | |||||
| Shiller PE Ratio | 17.67 | |||||
| PEG Ratio | 14.33 | |||||
| PS Ratio | 0.16 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 0.99 | |||||
| Price-to-Free-Cash-Flow | 205.71 | |||||
| Price-to-Operating-Cash-Flow | 33.66 | |||||
| EV-to-EBIT | 4.64 | |||||
| EV-to-EBITDA | 3.97 | |||||
| EV-to-Revenue | 0.1 | |||||
| EV-to-FCF | 132.32 | |||||
| Price-to-Projected-FCF | 0.78 | |||||
| Price-to-DCF (Earnings Based) | 1.12 | |||||
| Price-to-DCF (FCF Based) | 17.85 | |||||
| Price-to-Median-PS-Value | 1.1 | |||||
| Price-to-Graham-Number | 0.75 | |||||
| Price-to-Net-Current-Asset-Value | 16.15 | |||||
| Earnings Yield (Greenblatt) % | 21.55 | |||||
| Forward Rate of Return (Yacktman) % | 5.7 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medipal Holdings Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 3,408,417 | ||
| EPS (TTM) (円) | 194.44 | ||
| Beta | 0.37 | ||
| Volatility % | 17.85 | ||
| 14-Day RSI | 45 | ||
| 14-Day ATR (円) | 46.479949 | ||
| 20-Day SMA (円) | 2570.2 | ||
| 12-1 Month Momentum % | 35.52 | ||
| 52-Week Range (円) | 1663 - 2683.5 | ||
| Shares Outstanding (Mil) | 212.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medipal Holdings Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medipal Holdings Corp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medipal Holdings Corp Frequently Asked Questions
What is Medipal Holdings Corp(TSE:7459)'s stock price today?
The current price of TSE:7459 is 円2512.00. The 52 week high of TSE:7459 is 円2683.50 and 52 week low is 円1663.00.
When is next earnings date of Medipal Holdings Corp(TSE:7459)?
The next earnings date of Medipal Holdings Corp(TSE:7459) is .
Does Medipal Holdings Corp(TSE:7459) pay dividends? If so, how much?
The Dividend Yield %  of Medipal Holdings Corp(TSE:7459) is 2.11% (As of Today), Highest Dividend Payout Ratio of Medipal Holdings Corp(TSE:7459) was 0.39. The lowest was 0.2. And the median was 0.25. The  Forward Dividend Yield % of Medipal Holdings Corp(TSE:7459) is 2.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers